Search research articles
Contact Us
Filters
Showing results (61-70 of 173) with videos related to
Page
of 18
Sort By:
Nature Reviews. Cardiology
|
November 26, 2009
Cardiovascular effects of relaxin: from basic science to clinical therapy
Xiao-Jun Du, Ross A D Bathgate, Chrishan S Samuel, et al.
Kidney International
|
May 20, 2004
Relaxin-1-deficient mice develop an age-related progression of renal fibrosis
Chrishan S Samuel, Chongxin Zhao, Courtney P Bond, et al.
Stem Cell Research
|
October 2, 2015
Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease
Simon G Royce, Matthew Shen, Krupesh P Patel, et al.
The American Journal of Pathology
|
June 6, 2009
Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury
Yuben Moodley, Daniel Atienza, Ursula Manuelpillai, et al.
Frontiers in Pharmacology
|
June 15, 2017
Epigenetic Modifications to H3K9 in Renal Tubulointerstitial Cells after Unilateral Ureteric Obstruction and TGF-β1 Stimulation
Timothy D Hewitson, Stephen G Holt, Sven-Jean Tan, et al.
Cardiovascular Research
|
February 5, 2003
Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype
Xiao-Jun Du, Chrishan S Samuel, Xiao-Ming Gao, et al.
Journal of Immunology Research
|
December 10, 2019
Distinct Redox Signalling following Macrophage Activation Influences Profibrotic Activity
Caitlin V Lewis, Antony Vinh, Henry Diep, et al.
The Journal of Investigative Dermatology
|
September 28, 2005
The relaxin gene knockout mouse: a model of progressive scleroderma
Chrishan S Samuel, Chongxin Zhao, Qing Yang, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 29, 2014
Serelaxin is a more efficacious antifibrotic than enalapril in an experimental model of heart disease
Chrishan S Samuel, Hasangika Bodaragama, Jacqueline Y Chew, et al.
Frontiers in Pharmacology
|
April 12, 2016
The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate
Chao Wang, Barbara K Kemp-Harper, Martina Kocan, et al.
Page
of 18
Search research articles
Search
Showing results (61-70 of 173) with videos related to
Sort By:
Page
of 18
Nature Reviews. Cardiology
|
November 26, 2009
Cardiovascular effects of relaxin: from basic science to clinical therapy
Xiao-Jun Du, Ross A D Bathgate, Chrishan S Samuel, et al.
Kidney International
|
May 20, 2004
Relaxin-1-deficient mice develop an age-related progression of renal fibrosis
Chrishan S Samuel, Chongxin Zhao, Courtney P Bond, et al.
Stem Cell Research
|
October 2, 2015
Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease
Simon G Royce, Matthew Shen, Krupesh P Patel, et al.
The American Journal of Pathology
|
June 6, 2009
Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury
Yuben Moodley, Daniel Atienza, Ursula Manuelpillai, et al.
Frontiers in Pharmacology
|
June 15, 2017
Epigenetic Modifications to H3K9 in Renal Tubulointerstitial Cells after Unilateral Ureteric Obstruction and TGF-β1 Stimulation
Timothy D Hewitson, Stephen G Holt, Sven-Jean Tan, et al.
Cardiovascular Research
|
February 5, 2003
Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype
Xiao-Jun Du, Chrishan S Samuel, Xiao-Ming Gao, et al.
Journal of Immunology Research
|
December 10, 2019
Distinct Redox Signalling following Macrophage Activation Influences Profibrotic Activity
Caitlin V Lewis, Antony Vinh, Henry Diep, et al.
The Journal of Investigative Dermatology
|
September 28, 2005
The relaxin gene knockout mouse: a model of progressive scleroderma
Chrishan S Samuel, Chongxin Zhao, Qing Yang, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 29, 2014
Serelaxin is a more efficacious antifibrotic than enalapril in an experimental model of heart disease
Chrishan S Samuel, Hasangika Bodaragama, Jacqueline Y Chew, et al.
Frontiers in Pharmacology
|
April 12, 2016
The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate
Chao Wang, Barbara K Kemp-Harper, Martina Kocan, et al.
Page
of 18